New drug aims to restore skin color in vitiligo patients

NCT ID NCT06905873

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This early-stage trial tests a new drug called FB102 in 64 adults with non-segmental vitiligo, a condition that causes white patches on the skin. Half will get the drug and half a placebo, both given by IV. The main goal is to check safety and see if the drug helps bring back skin color on the face.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FB102 (a drug given by IV infusion)
What this could lead to
If it works, this could point toward a new treatment to restore skin color in people with vitiligo.
What could go wrong
This is a very early Phase 1 trial with only 64 people, so it is primarily checking safety. It may not show clear benefit, and side effects are unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VITILIGO are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cornerstone Dermatology

    RECRUITING

    Coorparoo, Queensland, 4151, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Momentum Pukehoke

    RECRUITING

    Auckland, Auckland, 2120, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Novatrials

    RECRUITING

    Kotara, New South Wales, 2289, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Optimal Clinical Trials Central

    RECRUITING

    Auckland, Auckland, 1010, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Optimal Clinical Trials North

    RECRUITING

    Auckland, Auckland, 0632, New Zealand

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Skin & Cancer Foundation Australia - The Skin Hospital

    RECRUITING

    Darlinghurst, New South Wales, 2010, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.